4.7 Editorial Material

HDL particles and infection-related death: when size matters

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: a population-based cohort study of 30 195 individuals

Mads Harslof et al.

Summary: This study used NMR spectroscopy to measure HDL particle counts in 30,195 Danish individuals and further subdivided them according to particle size. The study found that a decrease in the number of small and medium HDL particles was associated with an increased incidence and mortality of infectious diseases. This suggests that low levels of HDL cholesterol may affect the risk of infectious diseases.

CARDIOVASCULAR RESEARCH (2023)

Review Cardiac & Cardiovascular Systems

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?

Nick S. Nurmohamed et al.

Summary: Cholesteryl ester transfer protein (CETP) is a liver-synthesized glycoprotein that facilitates the transfer of cholesterol esters and triglycerides between different lipoprotein particles. Recent studies have shown that the benefit of CETP inhibitors in atherosclerotic cardiovascular disease (ASCVD) is primarily due to the reduction of LDL-C and apoB, rather than an increase in HDL-C. Genetic evidence supports the use of CETP inhibitors, as they achieve similar reductions in ASCVD risk as other lipid-lowering medications. The newest generation of CETP inhibitors not only lower LDL-C, but also reduce the risk of new-onset diabetes and improve glucose tolerance and insulin sensitivity.

CARDIOVASCULAR RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis

Mark Trinder et al.

Summary: Clinical genetics and humanized mouse models suggest that inhibiting CETP may preserve high-density lipoprotein levels and improve outcomes for individuals with sepsis.

CIRCULATION (2021)

Article Multidisciplinary Sciences

A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals

Joris Deelen et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation: the role of HDL

Fabrizia Bonacina et al.

CURRENT OPINION IN LIPIDOLOGY (2019)

Article Cardiac & Cardiovascular Systems

U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies

Christian M. Madsen et al.

EUROPEAN HEART JOURNAL (2018)

Article Biochemistry & Molecular Biology

Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys

Mathieu R. Brodeur et al.

JOURNAL OF LIPID RESEARCH (2017)

Article Cardiac & Cardiovascular Systems

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Stephen J. Nicholls et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Review Cardiac & Cardiovascular Systems

HDL in innate and adaptive immunity

Alberico Luigi Catapano et al.

CARDIOVASCULAR RESEARCH (2014)

Article Medicine, General & Internal

Effects of torcetrapib in patients at high risk for coronary events

Philip J. Barter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, Research & Experimental

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

Tomas Vaisar et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)